HuidaGene Therapeutics, a global clinical-stage biotechnology company focused on advancing CRISPR-based genomic medicines, and Synthego Corporation, a leading provider of innovative CRISPR solutions for...
Synthego Corp, a leading provider of genome engineering solutions, has announced the launch of Express Knockout Cell Pools, a new product offering that revolutionizes access...
Synthego, the genome engineering company, announced it has raised $200 million of growth capital, including a Series E financing led by Perceptive Advisors. Also...
